|
December 28, 2012
A stroke-preventing pill from Pfizer and Bristol-Myers Squibb won approval from U.S. health regulators, setting the stage for a fierce fight among drug makers to replace the widely used bloodthinner warfarin.
Read entire article on WSJ
|
rss
